atazanavir sulfate has been researched along with tacrolimus in 2 studies
Studies (atazanavir sulfate) | Trials (atazanavir sulfate) | Recent Studies (post-2010) (atazanavir sulfate) | Studies (tacrolimus) | Trials (tacrolimus) | Recent Studies (post-2010) (tacrolimus) |
---|---|---|---|---|---|
1,102 | 246 | 590 | 17,757 | 2,319 | 6,661 |
Protein | Taxonomy | atazanavir sulfate (IC50) | tacrolimus (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 7.18 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.58 | |
Cytochrome P450 3A5 | Homo sapiens (human) | 0.385 | |
Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.0021 | |
Peptidyl-prolyl cis-trans isomerase FKBP1A | Homo sapiens (human) | 0.2547 | |
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Homo sapiens (human) | 0.0148 | |
Splicing factor 3B subunit 3 | Homo sapiens (human) | 0.0123 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 3.3 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 3.7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aull, MJ; Figueiro, JM; Saal, SD; Tsapepas, DS; Webber, AB | 1 |
Gao, Y; Indulkar, AS; Raina, SA; Taylor, LS; Zhang, GGZ | 1 |
2 other study(ies) available for atazanavir sulfate and tacrolimus
Article | Year |
---|---|
Managing the atazanavir-tacrolimus drug interaction in a renal transplant recipient.
Topics: Anti-HIV Agents; Atazanavir Sulfate; Dose-Response Relationship, Drug; Drug Interactions; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Oligopeptides; Pyridines; Tacrolimus | 2011 |
Crystallization from Supersaturated Solutions: Role of Lecithin and Composite Simulated Intestinal Fluid.
Topics: Algorithms; Atazanavir Sulfate; Calcium Channel Blockers; Crystallization; Dihydropyridines; HIV Protease Inhibitors; Humans; Immunosuppressive Agents; Intestinal Secretions; Lecithins; Pharmaceutical Preparations; Ritonavir; Solubility; Solutions; Tacrolimus | 2018 |